$8.94 0.00 (%) Supernus Pharmaceuticals Inc - NASDAQ

Dec. 18, 2014 | 04:00 PM

Partner Headlines

  1. Supernus Announces Paragraph IV ANDA Filing for Oxtellar XR

    Benzinga | Dec. 10, 2014 | 07:30AM EST
  2. Supernus Reports Issuance of Fifth US Patent Protecting Trokendi XR(R)

    Benzinga | Nov. 24, 2014 | 07:33AM EST
  3. Third Quarter Was Robert Bruce's Busiest in 2014

    GuruFocus | Nov. 21, 2014 | 17:09PM EST
  4. Earnings Scheduled For November 11, 2014

    Benzinga | Nov. 11, 2014 | 04:56AM EST
  5. Supernus Offers Business Update: Reaffirms Does Not Need Added Capital, Will 'Explore a Broad Range of Strategic Opportunities'

    Benzinga | Sep. 22, 2014 | 16:16PM EST
  6. Morning Market Movers

    Benzinga | Aug. 12, 2014 | 09:42AM EST
  7. Earnings Scheduled For March 12, 2014

    Benzinga | Mar. 12, 2014 | 05:09AM EST
  8. Supernus Pharma Announces Data from Phase III PROSPER Study on Oxtellar XR Showed Potential Boost to Tolerability

    Benzinga | Feb. 3, 2014 | 07:32AM EST
  9. Stocks Hitting 52-Week Highs

    Benzinga | Jan. 27, 2014 | 10:54AM EST
  10. Morning Market Movers

    Benzinga | Dec. 24, 2013 | 09:59AM EST
  11. Benzinga's Top #PreMarket Gainers

    Benzinga | Dec. 24, 2013 | 08:09AM EST
  12. Stocks To Watch For December 24, 2013

    Benzinga | Dec. 24, 2013 | 04:13AM EST
  13. Merger Monday Lives Up To Its Name: 33.175 Billion In Deals

    Benzinga | Dec. 16, 2013 | 15:41PM EST
  14. Benzinga's Top Pre-Market Gainers

    Benzinga | Aug. 19, 2013 | 08:11AM EST
  15. Supernus Pharma Reports Final FDA Approval, Expected Upcoming Launch of Trokendi XR

    Benzinga | Aug. 19, 2013 | 07:34AM EST
  16. Supernus Prices 6M Share Public Offering at $8/Share

    Benzinga | Nov. 29, 2012 | 23:16PM EST
  17. Supernus Pharmaceuticals Reports Positive Phase IIb Results on SPN-810 for Treatment of Impulsive Aggression in ADHD Patients

    Benzinga | Nov. 20, 2012 | 14:43PM EST
  18. UPDATE: Piper Jaffray Reiterates Overweight Rating, Raises PT on Supernus Pharmaceuticals

    Benzinga | Aug. 13, 2012 | 06:19AM EST
  19. Supernus Appoints Dr. Stefan Schwabe, MD, PhD as Exec. VP R&D and Chief Medical Officer

    Benzinga | Jul. 20, 2012 | 02:01AM EST
  20. Jim Cramer Says Take Profits on Synacor and Supernus Pharmaceuticals

    Benzinga | Jul. 19, 2012 | 12:28PM EST
  21. Supernus Pharma Pops 25% on Tentative FDA Approval

    Benzinga | Jul. 6, 2012 | 08:22AM EST
  22. Supernus Pharmaceuticals Down Nearly 10%

    Benzinga | Jun. 28, 2012 | 05:02AM EST
  23. Three Tech IPOs Seek To Break The Facebook Curse

    IBD | Jun. 26, 2012 | 06:43AM EST
  24. Supernus Pharmaceuticals Skyrockets on FDA Approval

    Benzinga | Jun. 26, 2012 | 06:13AM EST
  25. Stocks Hitting 52-Week Highs

    Benzinga | Jun. 26, 2012 | 04:01AM EST
  26. Morning Market Movers

    Benzinga | Jun. 26, 2012 | 03:48AM EST
  27. Benzinga's Top Pre-Market Gainers

    Benzinga | Jun. 26, 2012 | 02:17AM EST
  28. UPDATE: Citi Initiates Coverage on Supernus Pharmaceuticals

    Benzinga | May. 29, 2012 | 02:46AM EST
  29. Piper Jaffray Initiates Coverage on Supernus Pharmaceuticals

    Benzinga | May. 29, 2012 | 02:17AM EST
Trading Center